Skip Navigation

Alere Inc.

First Check Diagnostics, LLC is owned and operated by Alere Inc., which is a major global developer, manufacturer, and marketer of advanced, pioneering consumer and professional medical diagnostic products.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere’s global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women’s health. Alere is headquartered in Waltham, Massachusetts.

With major R&D facilities based in the US, UK, Germany, and Israel, and manufacturing sites in China, Japan, the UK, and the US, Alere is truly global in scope.

For more information about Alere, please visit www.alere.com.

Research & Development Expertise

All First Check products go through rigorous analysis to ensure the highest level of quality. Clinical studies are performed on all of our products, determining their effectiveness, accuracy, and precision. At First Check, we have a strong commitment to bringing you innovation that is in touch with your needs.

What superior R&D has brought to First Check:

  • First to market with drug cup technology
  • First to market with prescription drug testing
  • Substance Abuse and Mental Health Services Administration (SAMHSA) standardized cut-off levels for illicit drugs

First Check is the first to bring the easy to use one-step cup technology to market. This cup technology offers hygienic testing and simple activation to ensure the least amount of human error.

First Check was the first to offer a home drug test that can not only identify the possible use of illicit drugs but can also identify the possible use of five of the most commonly abused prescription drugs.

The cut-off levels for our First Check® Home Drug Tests for illicit drugs are those standardized under the federal government guidelines issued by the National Institute on Drug Abuse (NIDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA).

Our Information Partner

Dr. Barbara A. Krantz

Chief Medical Officer, Hanley Center

Dr. Barbara A. KrantzDr. Barbara Krantz has practiced medicine in South Florida for over twenty-seven years. As Chief Medical Officer at Hanley Center, West Palm Beach, Florida, she draws from a wealth of experience in addiction medicine and family medicine.

Prior to joining Hanley Center in 2001, Dr. Krantz was the Medical Director for the Center for Alcohol and Drug Studies. She had earlier been the Medical Director at Cornerstone, a substance abuse treatment program at Wellington Regional Medical Center, and maintained a private family practice that included pediatrics and geriatrics.

Dr. Krantz has also served as Clinical Assistant Professor of Behavioral Medicine at Nova Southeastern University in North Miami Beach, and in 1999 developed the Inner City Outreach Program and the Medical Mobile Unit of West Palm Beach, the first such project undertaken in Palm Beach County. Dr. Krantz has had institutional affiliations including St. Mary’s and Good Samaritan Hospitals in Palm Beach County. She is Founder and Board President of His Great Commission, Inc., providing free medical screening, outreach and referral, and basic medical care primarily to Caribbean-American and Hispanic residents of Palm Beach County.

Dr. Krantz is a member of numerous medical associations including the American Society of Addiction Medicine. She is widely consulted as an addictionologist and has lectured on the biochemistry of the brain as it relates to addiction, the disease concept of chemical dependency, and signs and symptoms that emergency room physicians can look for in identifying addicted patients. She is currently teaching at the University of Miami School of Medicine at Florida Atlantic University as an assistant professor of Biomedical Sciences, was a mentor at Nova Southeastern University and teaches in the Hanley Center professional program.

Dr. Krantz received a Bachelor of Science degree and was class valedictorian at Manhattanville College in Purchase, New York. At the University of Miami (Florida) she graduated Phi Kappa Phi with a Master of Science degree and was class valedictorian. After studying at Des Moines University, Health Sciences, she served an internship at the Southeastern College of Osteopathic Medicine in North Miami Beach. She completed her family practice residency at Miami’s Jackson Memorial Hospital. In 2006 Dr. Krantz was certified by the Medical Review Officer Certification Council (MROCC) as a Medical Review Officer. Certified MROs evaluate drug and alcohol test results in the workplace.